Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2000Diabetic Medicine

Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus

View Full Paper
Ask AI
Bookmark
Share

Authors

JNJohn J. NolanTrinity College DublinNJN. P. JonesGlaxoSmithKline (United Kingdom)RPRita PatwardhanGlaxoSmithKline (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nolan et al. (2000) studied this question.

synapsesocial.com/papers/6a819e31b7134f4e3dee2096https://doi.org/10.1046/j.1464-5491.2000.00269.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sulfonylureas in NIDDM1992 · 405 citations
  2. 2Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes1996 · 1,001 citations
  3. 3An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)1995 · 3,650 citations
  4. 4Repeat Treatment of Obese Mice With BRL 49653, a New Potent Insulin Sensitizer, Enhances Insulin Action in White Adipocytes: Association With Increased Insulin Binding and Cell-Surface GLUT4 as Measured by Photoaffinity Labeling1995 · 140 citations